CDC Encourages Clinicians to Prioritize Antiviral Treatment of Influenza in the Setting of Reduced Availability of Oseltamivir
Published: 12/16/2022
Sources:
- Centers for Disease Control and Prevention
Relevant To:
- All Healthcare Organizations
The Centers for Disease Control and Prevention (CDC) estimates that in the 2022-2023 season to date, there have been at least 13 million illnesses, 120,000 hospitalizations, and 7,300 deaths from influenza. While the Food and Drug Administration (FDA) has not formally indicated shortages of oseltamivir (generic or Tamiflu) in any of its forms (capsules, oral suspension), CDC has received numerous anecdotal reports of availability issues for generic oseltamivir in some locations. The CDC acknowle…
Sign Up for Free Trial